Cy3-UTP ÒÖÖÆ¼Á BMPO Leukotriene D4 Ó«¹âȾÁÏ DMAPP ¶¨ÖƺϳÉ
Ò»Á×ËáÁò°·ÂÈ»¯Îï¶þË®ºÏÎïÓ¢ÎÄÃû£º3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium chloride hydrate (1:1:2)
1¡¢Ò»Á×ËáÁò°·ÂÈ»¯Îï¶þË®ºÏÎïÎïÀí²ÎÊý£º
³£ÓÃÃû
3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium chloride hydrate (1:1:2)
Ó¢ÎÄÃû
CASºÅ
273724-21-3
·Ö×ÓÁ¿
416.818
ÃܶÈ
N/A
·Ðµã
·Ö×Óʽ
C12H22ClN4O6PS
ÈÛµã
ÉÁµã
2¡¢Ò»Á×ËáÁò°·ÂÈ»¯Îï¶þË®ºÏÎïÎïÀí»¯Ñ§ÐÔÖÊ£º
3¡¢Ò»Á×ËáÁò°·ÂÈ»¯Îï¶þË®ºÏÎïÓ¢ÎıðÃû£º
4¡¢Ò»Á×ËáÁò°·ÂÈ»¯Îï¶þË®ºÏÎïÎÄÏ×£º
Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc. Natl. Acad. Sci. U. S. A. 103 , 15835-40, (2006) Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease. Metab. Brain Dis. 11 , 81-88, (1996) Regional alterations of thiamine phosphate esters and of thiamine diphosphate-dependent enzymes in relation to function in experimental Wernicke's encephalopathy. Neurochem. Res. 20 , 87-93, (1995)
400-186-1816
ÖÜÒ»ÖÁÖÜÎ壺8:30-17:30
¹ú¼Ò·¨¶¨½Ú¼ÙÈÕ³ýÍâ
±¾ÍøÕ¾ÏúÊÛµÄËùÓвúÆ·½öÓÃÓÚ¿ÆÑеȷÇÒ½ÁÆÓÃ;£¬·ÇÒ©Æ·²»¿ÉʳÓ㬲»¿ÉÓÃÓÚÈËÌå»ò¶¯ÎïµÄÁÙ´²Õï¶ÏºÍÖÎÁÆ¡£ÎÒÃDz»Îª¸öÈËÌṩ²úÆ·¼°·þÎñ¡£
Copyright © 2020-2025 MedBio All Rights Reserved ÉϺ£BJL,BJLƽ̨ҽҩ¿Æ¼¼ÓÐÏÞ¹«Ë¾
Ñϸñ½ûÖ¹ÔÚδ¾Í¬ÒâµÄÇé¿öÏÂ×ªÔØ±¾ÍøÕ¾Ö®ËùÓÐÐÅÏ¢¡£ÈçÐèÊÚȨ£¬ÇëÁªÏµÎÒ˾¡£
»¦¹«Íø°²±¸ 31011402010197ºÅ | | »¦ICP±¸2020034979ºÅ
MedBio¿Í·þ1
MedBio¿Í·þ2
MedBio¿Í·þ3
MedBio¿Í·þ4
MedBio¿Í·þ5
MedBio¿Í·þ6